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Dendritic cells (DCs) are a critical component of anti-tumor immunity due to their ability to induce a
robust immune response to antigen (Ag). Alcohol was previously shown to reduce DC ability to present
foreign Ag and promote pro-inﬂammatory responses in situations of infection and trauma. However the
impact of alcohol exposure on generation of an anti-tumor response, especially in the context of gen-
eration of an immune vaccine has not been examined. In the clinic, DC vaccines are typically generated
from autologous blood, therefore prior exposure to substances such as alcohol may be a critical factor to
consider regarding the effectiveness in generating an immune response. In this study, we demonstrate
for the ﬁrst time that ethanol differentially affects DC and tumor Ag-speciﬁc T cell responses depending
on sex. Signaling pathways were found to be differentially regulated in DC in females compared to males
and these differences were exacerbated by ethanol treatment. DC from female mice treated with ethanol
were unable to activate Ag-speciﬁc cytotoxic T cells (CTL) as shown by reduced expression of CD44, CD69,
and decreased production of granzyme B and IFNg. Furthermore, although FOXO3, an immune sup-
pressive mediator of DC function, was found to be upregulated in DC from female mice, ethanol related
suppression was independent of FOXO3. These ﬁndings demonstrate for the ﬁrst time differential im-
pacts of alcohol on the immune system of females compared to males and may be a critical consideration
for determining the effectiveness of an immune based therapy for cancer in patients that consume
alcohol.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The impact of alcohol on cancer risk remains inconclusive due to
seemingly conﬂicting data in several reports (Allen et al., 2009;
Brandon-Warner, Walling, Schrum, & McKillop, 2012; Fowke,
Howard, Andriole, & Freedland, 2014; Garcia-Lavandeira, Ruano-
Ravina, & Barros-Dios, 2016; Gong, Kristal, Schenk, Tangen,
Goodman,& Thompson, 2009; Meadows& Zhang, 2015; Newcomb
et al., 2013; Zhang, Zhu, Meadows, & Zhang, 2015). These con-
ﬂicting reports may be partially due to the study of different types
of cancer, such as prostate, liver, breast, lung and melanoma, but
also are due in large part to direct effects of alcohol on the immune
system. The immune system, especially the adaptive immune2160 S. 1st Ave, Maywood, IL
.
Inc. This is an open access article uresponse, is critical for recognition and destruction of tumor cells.
Cytotoxic T cells (CTL) recognize tumor associated antigens by
major histocompatibility complex (MHC) I mechanisms which
trigger release of Granzyme B, IFNg and promote lytic responses to
destroy tumor cells. Alcohol has been shown to have dramatic ef-
fects on the adaptive immune response including inhibiting T and B
cell development (Zhang, Zhu, Zhang, & Meadows, 2015). Alcohol
was also found to have substantial effects on macrophages (Goral,
Choudhry, & Kovacs, 2004) and in DC populations harvested from
ethanol fed mice (Heinz & Waltenbaugh, 2007; Lau, Abe, &
Thomson, 2006). However, studies have not examined the impact
of alcohol on the efﬁcacy of an immune therapy which includes
dendritic cell (DC) activation and function of tumor antigen (Ag)
speciﬁc T cells. Alcohol can have dramatic effects on the immune
cells directly or mediate changes in the tumor microenvironment
(TME) that lead to immune tolerance in favor of immune activation.
For example, increases in indolamine 2-3-dideoxygenase (IDO),nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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suppressing in the TME. IDO catabolizes tryptophan and leads to
inhibition of T cell proliferation and activation (Platten, von Knebel
Doeberitz, Oezen, Wick, & Ochs, 2014; Xiao, Liu, & Link, 2004).
Additionally, alcohol can up-regulate signaling pathways which can
be detrimental in the generation and activation of immune re-
sponses providing protection from tumor development such as
MAPK, AKT and SGK (Ebert et al., 2016; Goral et al., 2004; Ho et al.,
2012; Huang et al., 2015; Morelli et al., 2010). Given the recent rise
in use and promise of immune therapies for cancer, this may be an
important aspect to consider when deciding on an appropriate
treatment regimen (Boudewijns, Bloemendal, Gerritsen, de Vries,&
Schreibelt, 2016; Linch & Redmond, 2016). In the current study, we
demonstrate for the ﬁrst time that ethanol has a signiﬁcant inﬂu-
ence on DC from female but not male activation and effector
function of tumor-Ag speciﬁc T cells.Methods
Experimental mice
C57BL/6, male and female mice aged 6e8 weeks were obtained
from Jackson laboratories. FOXO3/ were bred from previously
acquired generous gift from Dr. Karen Arden (UCSD). Tyrosinase
related protein 2 (TRP2) Ag-speciﬁc T cells were obtained from
24H9mice, obtained fromNCI-Frederick. For in vitro studies, C57BL/
6 mice were used as a source of bone marrow derived dendritic
cells (BMDC). Mice were housed under speciﬁc pathogen-free
conditions and were treated in accordance with NIH guidelines
under protocols approved by the animal care and use committee
(IACUC) of Loyola University Chicago. (Maywood, IL).Cell isolations
TRP2 T cells were isolated by gently rolling lymph nodes har-
vested from 24H9 mice between frosted glass slides into PBS þ2%
FBS. The single cell suspension generated by this method is 99%
CD8þ TRP-Ag speciﬁc T cells as 24H9 mice are on a Rag2/
background, thus they only have CD8 cells with the speciﬁc T cell
receptor (TcR) (Singh, Ji, Feigenbaum, Leighty, & Hurwitz, 2009).Bone marrow cell differentiation
Bone marrow was taken from the tibia and ﬁbula of 6e8 week
old male or female mice and treated with AKC lysis buffer to
remove red blood cells. Remaining cells were plated in complete
RPMI supplemented with 20 ng/mL GM-CSF (Thompson et al.,
2015). Media was changed every other day for 9 days to direct
differentiation of dendritic cells. After nine days of differentiation
BMDCs were plated at a concentration of 1  106/ml and were
treated for 3 h with 50 mM ethanol. After ethanol pre-treatment
cells were stimulated with 100 ng/mL LPS for 12 h.Ethanol treatments
Cells were plated in RPMI media þ5% FBS and left untreated or
treated with ethanol at 2.5, 25 and 50 mM concentrations. To avoid
evaporation during treatment cells cultures were placed in plastic
sealed containers with additional ethanol maintained in beaker
outside of the well. (Garcia-Lavandeira et al., 2016). Absolute
ethanol was purchases from Sigma-Aldrich and used for all ethanol
treatments (D'Souza El-Guindy et al., 2010).Western blots and immunoprecipitations
Whole cell lysates were generated from bone marrow derived
DCs using lauryl-maltoside (Sigma Aldrich) immunoprecipitation
buffer supplemented with protease inhibitor (Roche). Proteins
were run by electrophoresis on a 4e15% gradient polyacrylamide
gel and transferred to a nitrocellulose membrane (Bio-Rad) Mem-
brane were blotted for FOXO3 using anti-FOXO3 antibody, anti-
MAPK p42/44 (ERK1/2), anti-AKT, anti-AKTp308, anti-SGKp (Cell
Signaling) or for b-Actin (Sigma-Aldrich) used to normalize protein
loading. Densitometry was calculated using Bio-rad Image Lab
software.
Flow cytometry
Cell suspensions were blocked with Fc block, washed, and
incubated with antibodies anti-CD11c, CD317 (PDCA-1), CD11b,
CD4, CD8, CD80, anti-CD86 and anti-MHCII (BD Pharmingen) or
anti-CD44, and anti-CD69 eBioscience for surface staining and
intracellular staining was performed on cells following surface
staining and treatment with ﬁx-perm buffer on ice for 30 min for
IL-12 and granzyme B, (eBioscience) (Thompson et al., 2015).
Proliferation
T cells were isolated from transgenic mice containing the TRP2
Ag T cell receptor. T cells were stimulated with control or ethanol
pre-treated DC loaded with TRP2 peptide for 48 h in RPMI sup-
plemented with 50 mM b-ME. Cultures were then stained for sur-
face markers indicated above and CFSE dilution was measured on
CD3þ/CD8þ cells by Flow cytometry detection as a measure of
proliferation (Thompson et al., 2015).
qRT-PCR
Cells were cultured as indicated above and DCs were harvested
for mRNA puriﬁcation using the Bio-Rad Aurum total RNA kit per
the manufacturer's instructions. RNA was isolated from DCs puri-
ﬁed from tumors by RNAeasy Spin Columns (Qiagen) per manu-
facturer's instructions. RNA quality was determined by analysis on
an Agilent bioanalyzer 2000. PCR reactions were run on a Quant-
Studio 6 using a Taqman assay system with primers for IDO, IL-10,
IL-6, TNF-a, b-actin, and GAPDH (Thompson et al., 2015). CT values
were determined by the Applied Biosystems 7300 SDS software.
Data were analyzed by the DDCT method. The DDCT uses the CT
values of the gene of interest (GOI) and housekeeping gene (HKG).
DCT is determined by subtracting the CT (HKG) from the CT (GOI),
and then the DDCT is determined by subtracting the DCT (control)
from the DCT (experimental). Fold change is equal to 2(DDCt).
ELISPOT
Multiscreen plates (Millipore) were coated with 100 ml of cap-
ture antibody (R&D Systems) overnight at 4 C. IFN-g (1  104)
puriﬁed TRP2 T cells were added to increasing concentrations of
peptide loaded control or ethanol pre-treated DC (WT or FOXO3/
). After incubation, plates were washed and processed.
Statistical analysis
To determine statistical signiﬁcance, data was analyzed using
descriptive and graphical techniques. Statistical analysis for differ-
ences between groups for cytokine production or gene expression
used the unpaired Student's t-test. Data generated with multi var-
iables was transformed to their common logarithms to satisfy
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ANOVAs. Statistically signiﬁcant differences in tumor growth was
determined using theWilcoxon rank sum test as described.With 10
mice per group, we have 80% power to detect a difference of 1.25
standard deviations across groups which is a reasonable effect size
for a preclinical study of this type in genetically identical mice. All
experiments were repeated 2e3 x for reproducibility.Results
Sex has an impact on gene expression and signaling pathway
activation in ethanol treated DC with or without additional
stimulation
Previous reports have described ethanol to have signiﬁcant
impacts on immune responses during situations of infection, in
response to burn injury or trauma. However, how ethanol may
impact immune function in response to a self and/or tumor antigen
has not been addressed. Our research has been focused on the
differential regulation of anti-tumor immunity based on sex,
therefore we wanted to determine whether ethanol could be a
compounding factor to the efﬁcacy of an immune therapy for the
treatment of cancer. One study by Olubadewo et al., demonstrated
that ethanol had more of an impact on male diabetic mice
compared to females in terms of cytokine production (Olubadewo
& Spitzer, 2003). Therefore, we began our studies by harvesting
bone marrow frommale and female mice and generating dendritic
cells (BMDC), such as those that would be used to develop a den-
dritic cell vaccine. BMDC were then treated with a high dose of
ethanol (50mM) for 3 h. Cytokines (IL-6 and TNF-a) and an enzyme
(IDO) important in the activation or suppression of T cells was then
assessed by qRT-PCR. In the DC from male mice, ethanol treatment
induced a statistically signiﬁcant increase in indolamine-2, 3-
dideoxygenase (IDO) a highly tolerogenic molecule to T cells.
However, changes in IL-6 and TNF-a were minimal under these
conditions. In contrast, DC from female mice had a signiﬁcant
reduction in IL-6 and a dramatic increase in both IDO and TNFa
(Fig. 1). Given the signiﬁcant differences in cytokine expression by
the male and DC from female mice after ethanol exposure, we
sought to detect differences in the activation of signaling pathways
that regulate these cytokines including AKT, SGK, MAPK and
FOXO3. Unexpectedly, there were differences in expression of each
of these factors between male and female BMDC even in the
absence ethanol. Speciﬁcally, phosphorylated SKG, phosphorylated
AKT and FOXO3were all upregulated in unstimulated female BMDC
compared to male (Fig. 2). These differences were compounded by
stimulation with lipopolysaccharide (LPS) and further modulatedFig. 1. Ethanol has higher impact on gene expression in DC from females. BM-DC were ge
for 3 h. DC were then lysed and mRNAwas isolated and tested by qRT-PCR for IDO, IL-10, IL-6
and female control samples compared to ethanol treated. B) Demonstrates ethanol treated c
as a baseline for ratio comparison. *p < 0.05, **p < 0.01. Data represent the mean of 9 indiv
references to colour in this ﬁgure legend, the reader is referred to the web version of thisby ethanol treatment. Although, we were unable to perform sta-
tistical analysis across 3 different gels from 3 different experiments,
which utilize 3 different sets of protein lysates, the pattern of up
and down regulation of each of the signaling molecules in response
to LPS and/or ethanol remained consistent. In male BMDC, phos-
phorylation of AKT increased in the presence of ethanol whether or
not an exogenous stimulation was received whereas ethanol in the
presence of LPS actually reduced phosphorylation of AKT in female
BMDC (Fig. 2A). Expression of total AKT was unchanged in both
populations conﬁrming that the regulation of AKT was at the
phosphorylation level (Fig. 2B). A similar result was observed with
phosphorylation of SGK. Male BMDC up regulated SGK-p with LPS
stimulation which was further upregulated by ethanol treatment,
however female BMDC decreased SGK-p upon LPS stimulation
which was not altered by the presence of ethanol (Fig. 2C). MAPK
regulation had yet another pattern of response, male BMDC
increased MAPK p42/44 in response to ethanol, however female
BMDC had a lower expression which was further decreased up
exposure to ethanol (Fig. 2D). Finally examination of FOXO3
expression demonstrated that although female BMDC expression of
FOXO3 is higher than male even in unstimulated control samples,
exposure to ethanol increased FOXO3 in both male and female
BMDC (Fig. 2E). We did not examine phosphorylation of FOXO3 in
DC, as our previous study demonstrates that in DC the mechanism
of action of FOXO3 is unphosphorylated FOXO3 binds and seques-
ters NF-kB to the cytoplasm to prevent pro-inﬂammatory signaling
(Thompson et al., 2015). These results demonstrate that there are
intrinsic differences in immune cell signaling between male and
females, but these differences are exacerbated by exposure to
ethanol. While it may be argued that the overall fold change in
these signaling molecules is small (1.5e3 fold), the fact that phos-
phorylation of AKT, SGK and MAPK are all impacted by ethanol
treatment and that total FOXO3, a critical molecule in immune
tolerance is signiﬁcantly up regulated in females upon ethanol
exposure suggest that these alterations hold biological signiﬁcance.
Decreases in MAPK phosphorylation in female support the ﬁndings
that IL-6 is highly up-regulated (Figs. 1 and 2D) and (Goral et al.,
2004). Increased FOXO3 expression can also be correlated to the
increase in IDO expression by DC treated with ethanol (Figs. 1 and
2E) and (Dejean et al., 2009). Taken together these data demon-
strate that ethanol is shifting DC phenotype, especially in females
from immune stimulatory to immune suppressive.Ethanol signiﬁcantly reduces IL-12 production by DC from female
but not male mice in response to tumor antigen
To determine the effect of ethanol on DC ability to stimulate Tnerated frommale and female mice. DC cultures treated with 50 mM ethanol (EtOH)
, TNFa and housekeeping genes b-actin and GAPDH. A) Demonstrates individually male
omparing male to female. The red line represents the 0 treated control gene expression
idual samples. Experiments were repeated a total of 3 times. (For interpretation of the
article.)
Fig. 2. Ethanol differentially impacts DC signaling depending on gender. BM-DC generated from male and female mice were cultured for 9 days and treated with 50 mM ethanol
(EtOH) for 3 h followed by LPS stimulation. DC were then lysed and assessed for accumulation of protein or phosphorylation of key signaling molecules involved in stimulating a
pro-inﬂammatory, anti-tumor immune response. Data are representative of 3 separate experiments. *p > 0.05.
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sion of MHC II and co-stimulatory molecules. DC were generated
from bone marrow from male and female CD57Bl/6 mice and
treated with ethanol or control media for 2 or 12 h. DC were then
fed B16 melanoma tumor lysate overnight for maturation and
activation. Activated DC were then stained for expression of CD80,
CD86 and MHC II and analyzed by ﬂow cytometry. No differences
were detected in regardless of the length of ethanol exposure
(Supplemental Fig. 1). Because T cells require 3 signals from DC for
proper activation, we next sought to determine whether pro-
inﬂammatory cytokine production important for T cell activation
was altered. DC were generated and treated the same as in the
previous experiment but were then tested for IL-12 production by
intracellular staining. DC from male mice produced a similar level
of IL-12 in response to a melanoma tumor antigen tyrosinase
related protein 2 (TRP2) regardless of ethanol exposure. However,
DC from female mice signiﬁcantly reduced IL-12 production (Fig. 3).
Although DC from female mice did still produce some IL-12,
because of the many differences in the signaling proﬁles of DC
from female mice compared to the male, this level of IL-12 may not
be sufﬁcient for T cell activation.Ethanol treated DC from females but not males have a reduced
capacity to stimulate tumor Ag-speciﬁc T cells
We next sought to determine the full effect of DC exposure toethanol on tumor Ag-speciﬁc T cell activation in males and females.
DC were generated from bone marrow and treated with control or
ethanol media for 2 or 12 h. For full potential to stimulate Ag-
speciﬁc T cells, DC were loaded with TRP2 peptides overnight.
Peptide loaded DC were then co-cultured with TRP2 Ag-speciﬁc T
cells labeled with CFSE for 48 h. T cells cultures were then stained
for additional surface markers, CD44 and CD69 as an indication of
activation and analyzed by ﬂow cytometry. Signiﬁcant differences
were detected upon examination of activationmarkers. TRP2 Tcells
stimulated with DC from male mice with or without ethanol had
high expression of both CD44 and CD69 indicating they have
received stimulationwith their cognate antigen and were activated
(Fig. 4A). In contrast, DC from female mice treated with ethanol for
only 2 h had a signiﬁcant reduction in CD69 expression which
demonstrates a reduced activation state and DC treated for 12 h
were completely incapable of stimulating either CD44 or CD69
expression (Fig. 4A). Interestingly, although CD44 expression is
down and would suggest the T cells were missing appropriate Ag
stimulation, as demonstrated by CFSE dilution there was no change
in either DC population's ability to stimulate T cell proliferation
even after 12 h of ethanol exposure (Fig. 4B).
To further determine the impact of ethanol the effectiveness of
an anti-tumor response, granzyme B production was measure by
intracellular staining and ﬂow cytometry. DC were generated and
treated as described above. Treated DC and TRP 2 Ag-speciﬁc T cells
were co-cultured for 12 h. T cells stimulated with TRP2 loaded DC
Fig. 3. Ethanol signiﬁcantly reduced IL-12 production in female but not male DC in response to tumor antigen. BM-DC generated from male and female mice were cultured for
9 days and treated with 50 mM ethanol (EtOH) for 3 h. DC were then activated by melanoma tumor lysate and tested for IL-12 production by intracellular staining. Data are
presented as MFI ± SD and are representative of 4 separate experiments. *p < 0.01.
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ethanol pre-treatment did not impact T cell stimulationwith the DC
from male mice, but did signiﬁcantly reduce granzyme B by T cells
stimulated with the DC from female mice (Fig. 5). Similar to the IL-
12 production by the DC, while these T cells do still express some
granzyme B, it is likely that their full cytotoxic T cell response
critical for generating anti-tumor immunity is signiﬁcantly altered
due to reduced effectiveness of DC exposed to ethanol.Ethanol reduces effectiveness of silencing FOXO3 in DC for tumor
vaccine
We and others have demonstrated that FOXO3 expression in DC
promotes immune tolerance in tumors, in response to virus and
overall T cell responses (Dejean et al., 2009; Koorella, Nair, Murray,
Carlson, Watkins, & Lee, 2014; Thompson et al., 2015; Tumurbaatar
et al., 2013). Because our previous studies were all in male mice
(Thompson et al., 2015), we ﬁrst wanted to verify administration of
a FOXO3/ DC vaccine enhanced anti-tumor immunity in female
mice. Female C57Bl/6 mice with B16 tumors were 1) left untreated
(black line), 2) injected I.P. with TRP2 peptide (red line), 3) given a
wild type DC vaccine where DC were loaded with TRP2 (blue line)
or 4) given a FOXO3/ DC vaccine where DC were loaded with
TRP2 (green line) (Fig. 6A). The untreated and TRP2 treated groups
succumb to tumor burden within 3 weeks of tumor injection, mice
receiving the WT DC vaccine had an initial regression of tumors
which rebounded approximately 30 days after injection, but mice
receiving FOXO3/ DC vaccine eradicated their tumors (Fig. 6A).
These data demonstrate that silencing FOXO3 in DC from female
mice (similar to previous ﬁndings in male) promotes generation of
an effective anti-tumor immune response.
Given that FOXO3 was upregulated in female BMDC compared
to male even in the absence of ethanol, we sought to determine
whether silencing FOXO3 could promote T cells responses when DCbecame exposed to ethanol. DC were generated from WT or
FOXO3/ bone marrow as previously described. BMDC's were
treated with low (2.5 mM) or moderate (25 mM) doses of ethanol
for 12 h. BMDC were then peptide loaded and used to stimulate
TRP2 T cells for IFNg production in an ELISPOT assay for 24 h. T cells
stimulated with FOXO3/ DC had a signiﬁcantly higher production
of IFNg compared to WT DC (Fig. 6B). Low dose of ethanol pre-
treatment had no effect on T cells from either DC treatment
group. However, DC exposed to moderate ethanol dosage resulted
in reduced T cell function in both the WT and FOXO3/ groups
(Fig. 6B). These data demonstrate that ethanol treatment of DC from
female mice results in a reduced ability to stimulate CTL's impor-
tant for anti-tumor immunity. This mechanism is independent of
FOXO3 induced immune suppression as previously described in
tumor associated DC (Thompson et al., 2015).Discussion
The option of immune therapy for the treatment of cancer is a
quickly growing and changing ﬁeld. Many successes have tran-
spired in recent years including the use of check-point inhibitors
such as anti-PD-1 and anti-CTLA-4 which support sustained T cell
function in the tumor microenvironment (Yun, Vincelette, Green,
Wahner Hendrickson, & Abraham, 2016). Additionally direct in-
jection of immune cells such as DC vaccines and adoptive T cell
transfer therapy have gained momentum in recent years
(Boudewijns et al., 2016; Yang et al., 2016). However, the success
rate of these therapies vary dramatically and the mechanisms
regulating these variances are poorly understood.
Many studies have implicated signiﬁcant impacts of ethanol on
host immune responses from inhibiting Tand B cell development to
(Barr, Girke, Sureshchandra, Nguyen, Grant, & Messaoudi, 2016;
Hemann, McGill, & Legge, 2014; Pasala, Barr, & Messaoudi, 2015;
Song et al., 2002) altering cytokine production and signaling in
Fig. 4. Ethanol treatment of DC does not impact tumor Ag speciﬁc T cell proliferation but does inhibit expression of activation markers in female T cells. TRP2 Ag speciﬁc
CD8þ T cells were labeled with CFSE to detect proliferation and co-cultured with peptide loaded control or ethanol pre-treated DC. T cells were assessed for A) activation markers
and B) proliferation 48 h after co-culture. Data are representative of 3 separate experiments.
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Deburghgraeve, Ramirez, & Kovacs, 2012; Qin et al., 2014;
Rendon, Janda, Bianco, & Choudhry, 2012). In each case, the effect
of ethanol on the immune system is varied depending on whether
it is a situation of acute or chronic exposure to ethanol and is
focused on immune responses to injury or foreign antigen such as
LPS, CPG or viral infection. Given the diversity of effects on different
immune cell populations in different settings, we hypothesized
that the response to a self and/or tumor antigen may also be
altered. DC generated for use as a DC vaccine are often generated
from patient blood, (Baar, 1999), whether autologous or allogeneic
these DC could be hampered in their ability to activate CTL toward
effective anti-tumor immunity due to prior exposure to ethanol. In
the current study, we focused on the direct effects of ethanol on
dendritic cells speciﬁcally in regard to their ability to stimulate
tyrosinase related protein 2, a melanoma tumor Ag-speciﬁc T cell(TRP2 T cells). Our preliminary studies on bone marrow derived DC
treatedwith ethanol quickly identiﬁed a signiﬁcant difference in DC
responses to ethanol depending on whether they were generated
from the bone marrow of a male or female mouse (Fig. 1). Given
these discrepancies all our studies were conducted side by side and
the data conclusively demonstrates that ethanol has a signiﬁcant
impact in decreasing anti-tumor immune stimulating ability of DC
from female but notmale mice. It could be argued that alcohol has a
more negative effect on estrogen or estrogen receptor signaling
compared to testosterone and androgen receptor, however, given
that these were DC generated in vitro in the absence of exogenous
hormones that is unlikely. Future in vivo studies are needed tomore
closely address the possibility of alcohol disruption of nuclear
hormone receptor activation.
In this study it was demonstrated that ethanol altered key
signaling pathways in DC generated from females but not males.
Fig. 5. Ethanol treatment of DC reduces CD8þ T cell granzyme B release in Females. TRP2 Ag speciﬁc CD8þ cytotoxic effector T cells were co-cultured with peptide loaded
DC ± ethanol pre-treatment. T cells were assessed for granzyme B production 12 h after co-culture by intracellular staining and ﬂow cytometry. Data are presented as MFI ± SD and
are representative of 2 separate experiments on 6 individual samples. *p < 0.03.
Fig. 6. Silencing FOXO3 enhances T cell response to tumor antigens but is still reduced by ethanol stimulation. A) Female C57BL/6 mice were injected subcutaneously with B16
melanoma, 10 days later tumor bearing mice received a DC vaccine with wild type or FOXO3/ peptide loaded DC. Tumors were measured every 3 days. Data displayed as
mean ± S.D. of 5 mice per group. *p < 0.05,**p < 0.01 B) TRP2 Ag speciﬁc CD8þ cytotoxic effector T cells were co-cultured with peptide loaded WT or FOXO3/ DC ± ethanol pre-
treatment. T cells were assessed for IFNg production 24 h after co-culture by ELISPOT. Data are presented as the average of triplicate wells ± SD. *p < 0.02. Data are representative of
2 experiments of 6 mice per group.
M.G. Thompson et al. / Alcohol 57 (2016) 1e8 7These changes further resulted in differential functions observed
including: DC from female mice exposed to ethanol had reduced IL-
12 production and failed to stimulate CTL upregulation of CD44 and
CD69, and further resulted in reduced CTL granzyme B and IFNg
production. Collectively the reduction in these import effector T cell
mechanisms would allow for tumor escape and growth.
Our previous work demonstrate that tumor associated DC that
fail to efﬁciently activate CTL are regulated by a transcription factor
FOXO3 which suppresses immunity by sequestering NF-kB to the
cytoplasm which inhibits pro-inﬂammatory signaling (Thompson
et al., 2015). These data led us to consider the possibility that
ethanol was upregulating FOXO3 in DC to a level that because
tolerance inducing. Although, we did see an increase in FOXO3
expression upon ethanol treatment, upon gene silencing FOXO3 in
DC, ethanol treatment still had a damning effect on DC stimulatory
ability demonstrating that the suppression of immunity by ethanol
is through a FOXO3 independent mechanism. The results of this
study are both biologically and statistically signiﬁcant, however, it
should be noted we have demonstrated these effects primarilyin vitro under an acute exposure to ethanol. In the clinic it is highly
unlikely that leukocytes taken from a patient to generate an im-
mune vaccine have had a single exposure to alcohol. This is a cur-
rent limitation of the study but given the important ﬁndings, future
studies are needed to determine the mechanism regulating DC
dysfunction induced by ethanol in females and the duration of the
effect. The identiﬁcation of the effects of ethanol in the female
immune system may be immediately beneﬁcial clinically as
appropriate courses of treatment are considered for anti-tumor
therapy.
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